William Blair Downgrades Lifecore Biomedical to Market Perform

9/28/2026
Impact: -50
Healthcare

William Blair analyst Max Smock has downgraded Lifecore Biomedical (NASDAQ: LFCR) from an 'Outperform' rating to 'Market Perform'. This change reflects a shift in the analyst's outlook on the company's performance.

AI summary, not financial advice

Share: